4//SEC Filing
AVANIR PHARMACEUTICALS, INC. 4
Accession 0001209191-14-076841
CIK 0000858803operating
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 8:55 PM ET
Size
17.3 KB
Accession
0001209191-14-076841
Insider Transaction Report
Form 4
OCAMPO CHRISTINE
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2014-12-16$2.59/sh+12,500$32,375→ 127,077 total - Sale
Common Stock
2014-12-18$16.93/sh−5,780$97,855→ 108,797 total - Sale
Common Stock
2014-12-16$16.94/sh−12,500$211,750→ 132,077 total - Exercise/Conversion
Common Stock
2014-12-16$4.18/sh+17,500$73,150→ 144,577 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-16−12,500→ 17,500 totalExercise: $2.59Exp: 2022-12-17→ Common Stock (12,500 underlying) - Sale
Common Stock
2014-12-16$16.94/sh−17,500$296,450→ 114,577 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-12-16−17,500→ 0 totalExercise: $4.18Exp: 2020-12-01→ Common Stock (17,500 underlying)
Footnotes (6)
- [F1]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
- [F2]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. A majority of the proceeds from the sales will be used to pay required withholdings due by the Reporting Person for vesting RSUs.
- [F3]Represents the weighted-average price at which shares were sold within a range between $16.92 and $16.95. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Represents the weighted-average price at which shares were sold within a range between $16.93 and $16.95. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]The option was granted on 12/17/2012 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
- [F6]The option was granted on 12/1/2010 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
Documents
Issuer
AVANIR PHARMACEUTICALS, INC.
CIK 0000858803
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000858803
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 8:55 PM ET
- Size
- 17.3 KB